BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 17886162)

  • 1. Pharmacological treatment of Alzheimer's dementia: state of the art and current dilemmas.
    Omerovic M; Hampel H; Teipel SJ; Buerger K
    World J Biol Psychiatry; 2008; 9(1):69-75. PubMed ID: 17886162
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The treatment of Alzheimer's disease: the approach from a clinical specialist in the trenches.
    Hake AM
    Semin Neurol; 2002 Mar; 22(1):71-4. PubMed ID: 12170395
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Psychopharmacology of noncognitive abnormal behaviors in Alzheimer's disease.
    Raskind MA
    J Clin Psychiatry; 1998; 59 Suppl 9():28-32. PubMed ID: 9720484
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Psychosis-related disturbances. Psychosis, agitation, and disinhibition in Alzheimer's disease: definitions and treatment options.
    Lesser JM; Hughes S
    Geriatrics; 2006 Dec; 61(12):14-20. PubMed ID: 17184138
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alzheimer's disease: clinical treatment options.
    Reichman WE
    Am J Manag Care; 2000 Dec; 6(22 Suppl):S1125-32; discussion S1133-8. PubMed ID: 11142177
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Atypical neuroleptics as a treatment of agitation and anxiety in Alzheimer's disease: risks or benefits.
    Moretti R; Torre P; Antonello RM; Pizzolato G
    Expert Rev Neurother; 2006 May; 6(5):705-10. PubMed ID: 16734518
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A longitudinal evaluation of behavioural and psychological symptoms of probable Alzheimer's disease.
    Eustace A; Coen R; Walsh C; Cunningham CJ; Walsh JB; Coakley D; Lawlor BA
    Int J Geriatr Psychiatry; 2002 Oct; 17(10):968-73. PubMed ID: 12325059
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Biological therapies of behavioral and psychological symptoms of dementia: update and prospects].
    Gallarda T; Olie JP
    Encephale; 2000; 26(3):72-80. PubMed ID: 10951909
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Drug treatment of emotional and cognitive dysfunction in dementia].
    Arsland D
    Tidsskr Nor Laegeforen; 1998 Feb; 118(4):560-5. PubMed ID: 9520584
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Treatment of agitation in dementia patients].
    González Salvador MT; Arango López C; Lyketsos CG
    Med Clin (Barc); 1999 Nov; 113(15):592-7. PubMed ID: 10605687
    [No Abstract]   [Full Text] [Related]  

  • 11. [Dementia and Alzheimer disease. Early detection and treatment].
    Ventura M
    Rev Med Brux; 1999 Sep; 20(4):A271-5. PubMed ID: 10523904
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacologic management of agitation in Alzheimer's disease.
    Profenno LA; Tariot PN
    Dement Geriatr Cogn Disord; 2004; 17(1-2):65-77. PubMed ID: 14564127
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beneficial effects of perospirone on aggressive behavior associated with dementia.
    Sato S; Mizukami K; Moro K; Tanaka Y; Asada T
    Psychiatry Clin Neurosci; 2006 Feb; 60(1):106-9. PubMed ID: 16472367
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Agitation and other noncognitive abnormalities in Alzheimer's disease.
    Deutsch LH; Rovner BW
    Psychiatr Clin North Am; 1991 Jun; 14(2):341-51. PubMed ID: 1676506
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risperidone and rivastigmine and agitated behaviour in severe Alzheimer's disease: a randomised double blind placebo controlled study.
    Holmes C; Wilkinson D; Dean C; Clare C; El-Okl M; Hensford C; Moghul S
    Int J Geriatr Psychiatry; 2007 Apr; 22(4):380-1. PubMed ID: 17380475
    [No Abstract]   [Full Text] [Related]  

  • 16. Amisulpride in the treatment of behavioural disturbances among patients with moderate to severe Alzheimer's disease.
    Mauri M; Mancioli A; Rebecchi V; Corbetta S; Colombo C; Bono G
    Acta Neurol Scand; 2006 Aug; 114(2):97-101. PubMed ID: 16867031
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Highlights from the annual scientific assembly: managing the stages of Alzheimer's disease--new management options.
    South Med J; 2002 Jan; 95(1):102-6. PubMed ID: 11827239
    [No Abstract]   [Full Text] [Related]  

  • 18. Neurotransmitter deficits in behavioural and psychological symptoms of Alzheimer's disease.
    Lanari A; Amenta F; Silvestrelli G; Tomassoni D; Parnetti L
    Mech Ageing Dev; 2006 Feb; 127(2):158-65. PubMed ID: 16297434
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Imaging treatment effects in Alzheimer's disease.
    Venneri A
    Magn Reson Imaging; 2007 Jul; 25(6):953-68. PubMed ID: 17446028
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Current and future medical treatment of Alzheimer's disease].
    Lemper JC
    Rev Med Brux; 2005 Sep; 26(4):S294-9. PubMed ID: 16240877
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.